Download Citation
Article Source:
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment
Koskimäki F,
Bernard J,
Yong J,
Arndt N,
Carroll T,
et al.
(2018)
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
PLOS ONE 13(12): e0209326.
https://doi.org/10.1371/journal.pone.0209326